News & Alerts
-
Mar- 2024 -15 March
Israel’s Gynica Starts Clinical Trial for Endometriosis Cure
Israeli biotechnology firm Gynica has embarked on an innovative journey towards developing a potential cure for endometriosis, a condition affecting…
Read More » -
15 March
Pandorum Technologies Secures USD 11 Million Investment to Advance Regenerative Therapy for Corneal Blindness
Pandorum Technologies, a leading biotechnology company specializing in tissue engineering and regenerative medicine, has announced the successful closure of a…
Read More » -
15 March
Biotheus Inc. and Hansoh Pharma Expand Strategic Collaboration for Cancer Treatment Advancements
Biotheus Inc. (Biotheus), a prominent clinical-stage biotech company specializing in biologics for oncology and inflammatory diseases, and Hansoh Pharmaceutical Group…
Read More » -
15 March
Global 3D Cell Cultures Market Set to Reach $14.8 Billion by 2028
BCC Research, a leading market research firm, has projected significant growth for the global 3D cell cultures market, estimating it…
Read More » -
13 March
Par Pharmaceutical Issues Recall for Treprostinil Injection Due to Silicone Particulates
Par Pharmaceutical, Inc. (Par), a subsidiary of Endo International plc based in Dublin, Ireland, has issued a voluntary nationwide recall…
Read More » -
7 March
Novo Market Valuation Surpasses Tesla on Experimental Obesity Drug Data
Novo Nordisk, has achieved a significant milestone by surpassing Tesla Inc. in market valuation following the promising results of its…
Read More » -
7 March
How to Manage Stress in Less Than 20 Minutes a Day
In our fast-paced world, stress has become an unwelcome companion for many of us. It’s easy to get overwhelmed by…
Read More » -
7 March
Calyx and Invicro Merge to Lead Medical Imaging Solutions for Clinical Research
Calyx and Invicro have reached an agreement to merge, forming a global leader in medical imaging and software solutions for…
Read More » -
7 March
Chemotherapy Induced Peripheral Neuropathy Treatment Market Projected to Hit $2.25 Billion by 2028
The chemotherapy-induced peripheral neuropathy (CIPN) treatment market is experiencing robust growth, with projections indicating a rise to $2.25 billion by…
Read More » -
7 March
US FDA Grants Orphan Drug Designation to iOnctura’s Autotaxin Cancer Therapy
iOnctura, a prominent clinical-stage biotechnology company dedicated to advancing revolutionary cancer therapies, has achieved a significant milestone with the recent…
Read More »